Caplin Point Laboratories Ltd

NSE: CAPLIPOINT · BSE: 524742 · Pharmaceuticals & Biotechnology · 25 announcements

Share price: ₹2,619.70
Market cap: ₹19,913 Cr
Revenue (annual): ₹2,187 Cr
Net profit (annual): ₹641.2 Cr
P/E (TTM): 29.9×Sector 47.4×
Promoter holding: 70.57%+0.00% QoQ
FII holding: 5.76%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Earnings Call 4 Financial Results 3 Regulatory Approval 2 Price Movement Clarification 2 Dividend 2 Business Update 2 Board Meeting Date 2 Annual General Meeting 2 Management Change 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

12 Aug 2026 14:58 IST NSE

Management Change

Caplin Point Laboratories Management Change

Caplin Point Laboratories re-appointed Dr. Sridhar Ganesan as Managing Director and appointed Mr. D. Muralidharan as Whole-Time Director. Both appointments are for two-year terms.

Read the filing ↗